Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.
Acute myeloid leukemia (AML), caused by abnormal proliferation and accumulation of hematopoietic progenitor cells, is one of the most common malignancies in adults. We reported here DYRK1A expression level was reduced in the bone marrow of adult AML patients, comparing to normal controls. Overexpres...
Main Authors: | Qiang Liu, Na Liu, Shaolei Zang, Heng Liu, Pin Wang, Chunyan Ji, Xiulian Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4047119?pdf=render |
Similar Items
-
Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
by: Na Liu, et al.
Published: (2015-01-01) -
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
by: Yihua Pang, et al.
Published: (2020-08-01) -
PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway
by: Liu Q, et al.
Published: (2019-12-01) -
DYRK1A activates NFATC1 to increase glioblastoma migration
by: Heng Liu, et al.
Published: (2021-09-01) -
Inhibition of MYC by the SMARCB1 tumor suppressor
by: April M. Weissmiller, et al.
Published: (2019-05-01)